PETROLATUM + RESORCINOL TOPICAL 55%-2% TOPICAL
Added to formulary September 2022 with restriction to pediatrics and infectious disease for patients that have failed therapy with Desitin.
Added to formulary September 2022 with restriction to pediatrics and infectious disease for patients that have failed therapy with Desitin.